Mayo Clinic Laboratory and pathology research roundup: June 14

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.

COVID-19 vaccines have been associated with a rare life-threatening thrombotic and thrombocytopenic adverse reaction, vaccine-induced immune thrombotic thrombocytopenia (VITT) characterized by high levels of platelet-activating anti-platelet factor 4 (PF4) antibodies. In this study, we evaluated the pathogenesis and clonality of VITT antibodies from five patients with VITT secondary to ChAdOx1 nCoV-19 (n=1) and Ad26.COV2.S (n=4) vaccination.

Read more.

Published to PubMed This Week

Meghann Southwick

Meghann Southwick is a marketing specialist for Mayo Clinic Laboratories. She has worked at Mayo Clinic since 2021.